of all five cell lines and compare their responsiveness to 4-hydroxytamoxifen (4-OHT) treatment. gene amplification and p53 genotyping was performed on all cell lines. A xenograft model in nude mice was utilized to assess the tumorigenic and metastatic abilities of the breast cancer cells. gene was rearranged in all cell lines. Low doses of 4-OHT induced proliferation of these breast cancer cell lines.All five breast cancer cell lines have different antigenic expression profiles, tumorigenicity and organ specific metastatic abilities although they derive from a single tumor. None of the studied markers correlated with tumorigenic potential. These new cell lines could serve as a model for detailed genomic and proteomic analyses to identify ...
IntroductionThe diversity of human breast cancer subtypes has led to the hypothesis that breast canc...
Cell lines are extremely useful tools in breast cancer research. Their key benefits include a high d...
Triple-negative breast cancer (TNBC) represents 10-20% of all human ductal adenocarcinomas and has a...
Background: Breast cancer cell lines are widely used tools to investigate breast cancer biology and ...
In search for treatments against breast cancer, cell lines are one of the basic resources, particula...
We aimed to generate and characterize a novel cell line from a breast cancer bone metastasis to bett...
The MCF-7 human breast cancer cell line and four derived variant sublines (R27, R3, R3–12, and R3–98...
Abstract Background Breast cancer cell lines are frequently used as model systems to study the cellu...
Breast cancer is one of the most common form of cancer among women globally and metastasis is the pr...
A new cell line (BRC-230) was established from surgical material of primary ductal infiltrating brea...
The establishment of two new breast cancer cell lines, MXT+ and MXT-, derived from the murine breast...
SummaryRecent studies suggest that thousands of genes may contribute to breast cancer pathophysiolog...
Abstract Background Among breast cancer (BC) patients the outcomes of anticancer therapy vary dramat...
BackgroundMonitoring and treating metastatic progression remains a formidable task due, in part, to ...
A new cell line, designated HDQ-P1, was successfully established from a primary ductal infiltrating ...
IntroductionThe diversity of human breast cancer subtypes has led to the hypothesis that breast canc...
Cell lines are extremely useful tools in breast cancer research. Their key benefits include a high d...
Triple-negative breast cancer (TNBC) represents 10-20% of all human ductal adenocarcinomas and has a...
Background: Breast cancer cell lines are widely used tools to investigate breast cancer biology and ...
In search for treatments against breast cancer, cell lines are one of the basic resources, particula...
We aimed to generate and characterize a novel cell line from a breast cancer bone metastasis to bett...
The MCF-7 human breast cancer cell line and four derived variant sublines (R27, R3, R3–12, and R3–98...
Abstract Background Breast cancer cell lines are frequently used as model systems to study the cellu...
Breast cancer is one of the most common form of cancer among women globally and metastasis is the pr...
A new cell line (BRC-230) was established from surgical material of primary ductal infiltrating brea...
The establishment of two new breast cancer cell lines, MXT+ and MXT-, derived from the murine breast...
SummaryRecent studies suggest that thousands of genes may contribute to breast cancer pathophysiolog...
Abstract Background Among breast cancer (BC) patients the outcomes of anticancer therapy vary dramat...
BackgroundMonitoring and treating metastatic progression remains a formidable task due, in part, to ...
A new cell line, designated HDQ-P1, was successfully established from a primary ductal infiltrating ...
IntroductionThe diversity of human breast cancer subtypes has led to the hypothesis that breast canc...
Cell lines are extremely useful tools in breast cancer research. Their key benefits include a high d...
Triple-negative breast cancer (TNBC) represents 10-20% of all human ductal adenocarcinomas and has a...